Development of an integrated risk stratification model for metastatic medulloblastoma (M2/3) using clinical, radiologic, and molecular variables
Our study provides a novel risk stratification model for metastatic medulloblastoma that could potentially facilitate the development of individualized therapeutic strategies for the very high-risk patient population.
Authors
- LU Yu-fei
- Chi Zhao (ORCID: https://orcid.org/0009-0009-9982-1549)
- Huabiao Zhao (ORCID: https://orcid.org/0000-0001-9121-4917)
- Tian Yong-ji
- Fu Zhao (ORCID: https://orcid.org/0000-0002-5286-5650)
- Shuxu Du (ORCID: https://orcid.org/0000-0002-2874-5712)
- Si-Kang Ren
- Tao Wu
- Wen-Tao Zhou
Institutions
- Capital Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- Beijing Sanbo Brain Hospital (CN)
- Beijing Institute of Neurosurgery (CN)
- Beijing Friendship Hospital (CN)
- Beijing Shijitan Hospital (CN)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1093/noajnl/vdaf265
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Dongcheng District People's Government